UofT researcher wins Bill and Melinda Gates foundation grant

The Bill and Melinda Gates foundation has announced the winners for the $100,000 for its Grand Challenge Exploration project. The grants are for research work directly or indirectly related to malaria.

Out of 4000 applications, only 104 won the grant. One of them is Ryan Lilien, a UofT Assistant Professor and researcher for their Computational Biology department.

The grant received by Dr. Lilien is to computationally model the structural and functional effects of point mutation on a target protein’s active site. This could be of significant importance in understanding protein mutation processes and assist the drug development of more effective anti-infective treatments.

Congrats to our home team!

Read more:

• Ryan Lilien and his research
• All Grand Challenges Explorations awarded grants

Related Blogs

 

$100,000 investment up for grabs from the Ontario Genomics Institute
The Ontario Genomics Institute is now accepting applications for its Pre-Commercialization Business Development Fund (PBDF), a unique investment fund that provides early-stage funding to researchers

"I get to scrounge around the biggest candy store in the world – that is Science"
Renowned immunologist and cancer biologist Dr. Tak Mak got the discussion off to an enthusiastic start last week at MaRS when he characterized what it was that “got him out of bed in the morning�

The future of medicine's so bright
Imagine a world where… drugs work reliably no one ever gets sick from their prescriptions harmful properties are designed out of all new drugs critically-ill patients entering the ICU expect a po

InDanio secures funding
The Ontario Genomics Institute announced today that it has awarded MaRS client InDanio BioScience $100,000 of development funding under its Pre-Commercialization Business Development Fund (see press

Toronto brings you the second genetic code
One surprising finding from the Human Genome Project was that our genome is of a relatively modest size compared to some lowly organisms (e.g. the marbled lungfish and the amoeba Polychaos dubium hav

Receptor Therapeutics raises $500,000
Receptor Therapeutics Inc. – a MaRS tenant – has raised $500,000 from the OICR’s IPDC Program via its OncoTek Drug Delivery Inc. subsidiary. The funds will be used to drive the pre

Tags: awards & competitions, biology, drug development, funding, genetics, life sciences, university of toronto